Lindstrom Carol — SEC insider filings
SEC reporting owner CIK 1677400. 37 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2020-08-06 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 247 shares, $4,977 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 17 legs across 17 filings — 36,960 shares, $2,243,194 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 4,916 shares @ $54.40 ($267,430) in Genpact LTD, filed 2025-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Genpact LTD (G) | Director | 15 | — | 9 legs · 26,744 sh · $1,254,195 | 6 |
| EXPONENT INC (EXPO) | Director | 14 | — | 6 legs · 8,156 sh · $793,364 | 18 |
| Everforth Inc (EFOR) | Director | 8 | 2 legs · 247 sh · $4,977 | 2 legs · 2,060 sh · $195,635 | 5 |
Insider filings — Lindstrom Carol
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Genpact LTD (G) | Sale (S): 2,364 @ $42.56 | EDGAR |
| 2026-06-04 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 2,009 · Option exercise (M): 2,009 (derivative) · Grant/award (A): 2,859 (derivative) | EDGAR |
| 2026-04-27 | 4 | Genpact LTD (G) | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-04-27 | 4 | Everforth Inc (EFOR) | Purchase (P): 240 @ $20.15 · Purchase (P): 7 @ $20.16 | EDGAR |
| 2026-01-06 | 4 | ASGN Inc (ASGN) | Grant/award (A): 4,500 @ $46.66 | EDGAR |
| 2025-08-13 | 4 | Genpact LTD (G) | Sale (S): 2,326 @ $43.17 | EDGAR |
| 2025-06-10 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 1,525 · Option exercise (M): 1,525 (derivative) · Grant/award (A): 2,009 (derivative) | EDGAR |
| 2025-05-27 | 4 | Genpact LTD (G) | Grant/award (A): 4,825 @ $0 | EDGAR |
| 2025-02-13 | 4 | Genpact LTD (G) | Sale (S): 4,916 @ $54.40 | EDGAR |
| 2025-01-06 | 4 | ASGN Inc (ASGN) | Grant/award (A): 2,232 @ $82.86 | EDGAR |
| 2024-11-14 | 4 | Genpact LTD (G) | Sale (S): 3,218 @ $46.57 | EDGAR |
| 2024-11-05 | 4 | EXPONENT INC (EXPO) | Sale (S): 1,039 @ $96.32 | EDGAR |
| 2024-10-25 | 4 | ASGN Inc (ASGN) | Sale (S): 1,060 @ $93.02 | EDGAR |
| 2024-07-30 | 4 | EXPONENT INC (EXPO) | Sale (S): 932 @ $107.14 | EDGAR |
| 2024-06-10 | 4 | EXPONENT INC (EXPO) | Grant/award (A): 1,525 (derivative) | EDGAR |
| 2024-06-06 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 1,506 · Option exercise (M): 1,506 (derivative) | EDGAR |
| 2024-05-06 | 4 | Genpact LTD (G) | Grant/award (A): 6,707 @ $0 | EDGAR |
| 2024-04-30 | 4 | ASGN Inc (ASGN) | Sale (S): 1,000 @ $97.04 | EDGAR |
| 2024-01-04 | 4 | ASGN Inc (ASGN) | Grant/award (A): 1,933 @ $95.67 | EDGAR |
| 2023-06-09 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 1,489 · Option exercise (M): 1,489 (derivative) · Grant/award (A): 1,506 (derivative) | EDGAR |
| 2023-05-08 | 4 | Genpact LTD (G) | Grant/award (A): 4,916 @ $0 | EDGAR |
| 2023-02-16 | 4 | Genpact LTD (G) | Sale (S): 4,308 @ $47.66 | EDGAR |
| 2023-02-08 | 4 | EXPONENT INC (EXPO) | Sale (S): 1,875 @ $106.59 | EDGAR |
| 2023-01-05 | 4 | ASGN Inc (ASGN) | Grant/award (A): 2,243 @ $82.46 | EDGAR |
| 2022-11-16 | 4 | Genpact LTD (G) | Sale (S): 2,703 @ $45.37 | EDGAR |
| 2022-06-17 | 4 | Genpact LTD (G) | Sale (S): 2,409 @ $42.49 | EDGAR |
| 2022-06-06 | 4 | EXPONENT INC (EXPO) | Grant/award (A): 1,489 (derivative) | EDGAR |
| 2022-06-03 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 1,474 · Option exercise (M): 1,474 (derivative) | EDGAR |
| 2022-05-23 | 4 | Genpact LTD (G) | Grant/award (A): 4,829 @ $0 | EDGAR |
| 2022-01-05 | 4 | ASGN Inc (ASGN) | Grant/award (A): 1,209 @ $124.06 | EDGAR |
| 2021-08-31 | 4 | EXPONENT INC (EXPO) | Sale (S): 880 @ $113.54 | EDGAR |
| 2021-08-11 | 4 | Genpact LTD (G) | Sale (S): 2,000 @ $50.49 | EDGAR |
| 2021-06-04 | 4 | EXPONENT INC (EXPO) | Option exercise (M): 1,675 · Option exercise (M): 1,675 (derivative) · Grant/award (A): 1,474 (derivative) | EDGAR |
| 2021-05-07 | 4 | Genpact LTD (G) | Grant/award (A): 3,709 @ $0 | EDGAR |
| 2021-02-11 | 4 | EXPONENT INC (EXPO) | Sale (S): 1,000 @ $94.45 | EDGAR |
| 2020-08-12 | 4 | Genpact LTD (G) | Sale (S): 2,500 @ $41.82 | EDGAR |
| 2020-08-06 | 4 | EXPONENT INC (EXPO) | Sale (S): 2,430 @ $81.98 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1677400 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs